Please note that Spasticity physiotherapy management pdf Explorer version 8. Please refer to this blog post for more information.
However, patients with neurological conditions make up a large proportion of general medical admissions and GP consultations. This review attempts to explain the process and how an understanding of this can improve the care of neurological patients in all settings. Spasticity management can be particularly challenging, but rewarding if physical and pharmacological measures are used appropriately and in a timely manner. Check if you have access through your login credentials or your institution.
New York, Cambridge University Press, 2008. The first edition of this textbook provided a practical guide and source of references for physicians, surgeons, therapists, orthotists, engineers and other health professionals who are involved in the management of the disabled person with spasticity. The second edition follows the same format. We have updated the chapters and provided new references and described new techniques.
We hope we have covered all aspects of management from physiotherapy, seating and positioning and orthoses to the use ofdrugs, intrathecaltechniquesandsurgery. We have also stressed the importance of adequate measurement techniques and, indeed, Chapter 3 has been completely rewritten by Garth R. Wehopethat clinicians will continue to find this book helpful and a useful source of reference in their own practise and that it will continue to provideasolidbaseforagreater understanding of the management of spasticity. It aims to reduce variation in practice and help healthcare professionals to select and use appropriate treatments.
In November 2016, recommendation 1. Is this guideline up to date? We reviewed the evidence in November 2016. We found no new evidence that affects the recommendations in this guideline.
This guideline was previously called spasticity in children and young people with non-progressive brain disorders: management of spasticity and co-existing motor disorders and their early musculoskeletal complications. The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.
Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties.